Compare AVTX & FLYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVTX | FLYE |
|---|---|---|
| Founded | 2011 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 248.3M | 8.5M |
| IPO Year | 2015 | 2024 |
| Metric | AVTX | FLYE |
|---|---|---|
| Price | $17.60 | $8.05 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $32.29 | N/A |
| AVG Volume (30 Days) | ★ 313.5K | 309.1K |
| Earning Date | 11-06-2025 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $192,000.00 | ★ $19,966,391.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.39 | $3.83 |
| 52 Week High | $20.72 | $166.00 |
| Indicator | AVTX | FLYE |
|---|---|---|
| Relative Strength Index (RSI) | 46.30 | 55.47 |
| Support Level | $18.58 | $5.28 |
| Resistance Level | $18.54 | $7.94 |
| Average True Range (ATR) | 1.28 | 0.80 |
| MACD | -0.23 | -0.12 |
| Stochastic Oscillator | 13.17 | 81.26 |
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
Fly-E Group Inc is an electric vehicle company that is principally engaged in designing, installing and selling smart electric motorcycles, electric bikes, electric scooters and related accessories under the brand Fly E-Bike. It also provides connectivity solutions and value-added services to their customers.